BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 26596585)

  • 1. Vascular mesangial channels in human nodular diabetic glomerulopathy.
    Cossey LN; Hennigar RA; Bonsib S; Gown AM; Silva FG
    Hum Pathol; 2016 Feb; 48():148-53. PubMed ID: 26596585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of idiopathic nodular glomerulosclerosis mimicking diabetic glomerulosclerosis (Kimmelstiel-Wilson type).
    Müller-Höcker J; Weiss M; Thoenes GH; Grund A; Nerlich A
    Pathol Res Pract; 2002; 198(5):375-9. PubMed ID: 12092775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular extracellular matrices in rat diabetic glomerulopathy by scanning electron microscopy.
    Makino H; Yamasaki Y; Hironaka K; Ota Z
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(1):19-24. PubMed ID: 1352071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerulopathy in spontaneously obese rhesus monkeys with type 2 diabetes: a stereological study.
    Najafian B; Masood A; Malloy PC; Campos A; Hansen BC; Mauer M; Caramori ML
    Diabetes Metab Res Rev; 2011 May; 27(4):341-7. PubMed ID: 21370383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SEM studies of acellular glomerular basement membrane in human diabetic glomerulopathy.
    Carlson EC; Surerus KK
    Anat Rec; 1986 Nov; 216(3):349-58. PubMed ID: 3789417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of mesangial expansion in the pathogenesis of diabetic nephropathy.
    Dalla Vestra M; Saller A; Mauer M; Fioretto P
    J Nephrol; 2001; 14 Suppl 4():S51-7. PubMed ID: 11798146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy.
    Makino H; Shikata K; Hironaka K; Kushiro M; Yamasaki Y; Sugimoto H; Ota Z; Araki N; Horiuchi S
    Kidney Int; 1995 Aug; 48(2):517-26. PubMed ID: 7564121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
    Okada M; Takemura T; Yanagida H; Yoshioka K
    Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesangial deposition of type I collagen in human glomerulosclerosis.
    Glick AD; Jacobson HR; Haralson MA
    Hum Pathol; 1992 Dec; 23(12):1373-9. PubMed ID: 1468774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of idiopathic nodular glomerulosclerosis with fibrin caps.
    Kinoshita C; Inoue Y; Kanda Y; Kanda C
    Clin Exp Nephrol; 2011 Dec; 15(6):937-41. PubMed ID: 21847522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of worn-out GBM material substantially contributes to mesangial matrix expansion in diabetic nephropathy.
    Kriz W; Löwen J; Federico G; van den Born J; Gröne E; Gröne HJ
    Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1101-F1111. PubMed ID: 28228399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions.
    Nerlich A; Schleicher E
    Am J Pathol; 1991 Oct; 139(4):889-99. PubMed ID: 1928305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetic glomerulosclerosis--a prolonged stage of diabetic glomerulopathy].
    Severgina ES; Ponomarev AB; Diuzheva TG; Shestakova MV; Maĭorova EM
    Arkh Patol; 1994; 56(4):50-5. PubMed ID: 7848106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy.
    Guo M; Ricardo SD; Deane JA; Shi M; Cullen-McEwen L; Bertram JF
    J Anat; 2005 Dec; 207(6):813-21. PubMed ID: 16367807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early mesangiolysis and monocyte influx observed in diabetic glomerulosclerosis: relation to nodule formation.
    Koda Y; Maruyama Y; Ogino S; Hayashi H; Nishi S; Saito T; Ueno H; Arakawa M
    Nihon Jinzo Gakkai Shi; 1991 Jan; 33(1):33-42. PubMed ID: 2038130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural involvement in type 1 and type 2 diabetic nephropathy.
    Dalla Vestra M; Saller A; Bortoloso E; Mauer M; Fioretto P
    Diabetes Metab; 2000 Jul; 26 Suppl 4():8-14. PubMed ID: 10922968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An electron microscopic study of circumferential mesangial interposition in various renal diseases].
    Maruyama Y
    Nihon Jinzo Gakkai Shi; 1998 May; 40(4):263-75. PubMed ID: 9654910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesangiolysis in diabetic glomeruli: its role in the formation of nodular lesions.
    Saito Y; Kida H; Takeda S; Yoshimura M; Yokoyama H; Koshino Y; Hattori N
    Kidney Int; 1988 Sep; 34(3):389-96. PubMed ID: 3172647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic classification of diabetic nephropathy.
    Tervaert TW; Mooyaart AL; Amann K; Cohen AH; Cook HT; Drachenberg CB; Ferrario F; Fogo AB; Haas M; de Heer E; Joh K; Noël LH; Radhakrishnan J; Seshan SV; Bajema IM; Bruijn JA;
    J Am Soc Nephrol; 2010 Apr; 21(4):556-63. PubMed ID: 20167701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal morphologic lesions reminiscent of diabetic nephropathy.
    Raparia K; Usman I; Kanwar YS
    Arch Pathol Lab Med; 2013 Mar; 137(3):351-9. PubMed ID: 23451746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.